Data / Form D filings / ONDINE BIOPHARMA Corp
ONDINE BIOPHARMA Corp: Form D filings
ONDINE BIOPHARMA Corp, a biotechnology company in Vancouver, filed 4 Form D notices with the SEC between 2009 and 2010. The latest, on April 7, 2010, reports $45,463 sold of a $45,463 offering to 3 investors.
Find out what ONDINE BIOPHARMA Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 910-1100 MELVILLE ST, Vancouver, V6E4A
- Phone
- (604) 669-0555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1286774
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2010 | New notice | $45,463 | $45,463 | $0 | 3 | Apr 5, 2010 | sec.gov |
| Dec 29, 2009 | New notice | $239,308 | $239,308 | $0 | 2 | Dec 23, 2009 | sec.gov |
| Dec 21, 2009 | New notice | $480,183 | $480,183 | $0 | 4 | Dec 7, 2009 | sec.gov |
| Sep 11, 2009 | New notice | $43,360 | $43,360 | $0 | 1 | Jun 24, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carolyn Cross | Executive Officer, Director | |
| Thomas Dawson | Executive Officer | |
| Colin Watt | Director | |
| Michael Crane | Director | |
| Terence Holland | Director | |
| Margaret Shaw | Director | |
| Merrill Biel | Director | |
| Nicholas Loebel | Executive Officer | |
| William Harper | Executive Officer |
Every Form D from the week of Apr 5, 2010 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ONDINE BIOPHARMA Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.